The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects
Abstract
Smad5 has been implicated as a downstream signal mediator for several bone morphogenetic proteins (BMPs). To understand the in vivo function of Smad5, we generated mice deficient in Smad5 using embryonic stem (ES) cell technology. Homozygous mutant embryos die between E9.5 and E11.5, and display variable phenotypes. Morphological defects are first detected at E8.0 in the developing amnion, gut and heart (the latter defect being similar to BMP-2 knockout mice). At later stages, mutant embryos fail to undergo proper turning, have craniofacial and neural tube abnormalities, and are edematous. In addition, several extraembryonic lesions are observed. After E9.0, the yolk sacs of the mutants contain red blood cells but lack a well-organized vasculature, which is reminiscent of BMP-4, TGF-β1 and TGF-β type II receptor knockout mice. In addition, the allantois of many Smad5 mutants is fused to the chorion, but is not well-elongated. A unique feature of the Smad5 mutant embryos is that ectopic vasculogenesis and hematopoiesis is observed in the amnion, likely due to mislocation of allantois tissue. Despite the expression of Smad5 from gastrulation onwards, and in contrast to knockouts of Smad2 and Smad4, Smad5 only becomes essential later in extraembryonic and embryonic development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TGF-β signalling from cell membrane to nucleus through SMAD proteins
Heldin, C.-H., Miyazono, K., & ten Dijke, P. (1997) · Nature · doi:10.1038/37284 · Cited by 3,696
Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Møller, N. P. H., Risau, W., & Ullrich, A. (1993) · Cell · doi:10.1016/0092-8674(93)90573-9 · Cited by 1,927
Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse.
Winnier, G., Blessing, M., Labosky, P. A., & Hogan, B. L. (1995) · Genes & Development · doi:10.1101/gad.9.17.2105 · Cited by 1,788
The Atlas of Mouse Development
Kaufman, M. H. (1992) · Medical Entomology and Zoology · Cited by 1,750
McAllister, K. A., Grogg, K. M., Johnson, D. W., Gallione, C. J., Baldwin, M. A., Jackson, C. E., Helmbold, E. A., Markel, D. S., McKinnon, W. C., Murrel, J., et al. (1994) · Nature Genetics · doi:10.1038/ng1294-345 · Cited by 1,482
The atlas of mouse development
Beddington, R. (1993) · Trends in Genetics · doi:10.1016/0168-9525(93)90071-o · Cited by 1,415
Risau, W., & Flamme, I. (1995) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.11.110195.000445 · Cited by 1,406
Congenital Heart Disease Caused by Mutations in the Transcription Factor NKX2-5
Schott, J.-J., Benson, D. W., Basson, C. T., Pease, W., Silberbach, G. M., Moak, J. P., Maron, B. J., Seidman, C. E., & Seidman, J. G. (1998) · Science · doi:10.1126/science.281.5373.108 · Cited by 1,308
Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis.
Molkentin, J. D., Lin, Q., Duncan, S. A., & Olson, E. N. (1997) · Genes & Development · doi:10.1101/gad.11.8.1061 · Cited by 1,150
Johnson, D. W., Berg, J. N., Baldwin, M. A., Gallione, C. J., Marondel, I., Yoon, S.-J., Stenzel, T. T., Speer, M., Pericak-Vance, M. A., Diamond, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0696-189 · Cited by 1,116
Cited by
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
Armulik, A., Genové, G., & Betsholtz, C. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.001 · Cited by 2,653
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Endothelial/Pericyte Interactions
Armulik, A., Abramsson, A., & Betsholtz, C. (2005) · Circulation Research · doi:10.1161/01.res.0000182903.16652.d7 · Cited by 2,048
Endothelial-Mural Cell Signaling in Vascular Development and Angiogenesis
Gaengel, K., Genové, G., Armulik, A., & Betsholtz, C. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.161521 · Cited by 933
The role of TGF-β signaling in myocardial infarction and cardiac remodeling
BUJAK, M., & FRANGOGIANNIS, N. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.002 · Cited by 927
Genetic Analysis of the Mammalian Transforming Growth Factor-β Superfamily
Chang, H., Brown, C. W., & Matzuk, M. M. (2002) · Endocrine Reviews · doi:10.1210/er.2002-0003 · Cited by 787
Self-citationAbnormal angiogenesis but intact hematopoietic potential in TGF‐β type I receptor‐deficient mice
Larsson, J., Goumans, M., Sjöstrand, L. J., van Rooijen, M. A., Ward, D., Levéen, P., Xu, X., ten Dijke, P., Mummery, C. L., & Karlsson, S. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1663 · Cited by 563
Regulation of cell proliferation by Smad proteins
Ten Dijke, P., Goumans, M., Itoh, F., & Itoh, S. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10066 · Cited by 450
BMP Type II Receptor Is Required for Gastrulation and Early Development of Mouse Embryos
Beppu, H., Kawabata, M., Hamamoto, T., Chytil, A., Minowa, O., Noda, T., & Miyazono, K. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9670 · Cited by 421
TGF-β superfamily expression and actions in the endometrium and placenta
Jones, R. L., Stoikos, C., Findlay, J. K., & Salamonsen, L. A. (2006) · Reproduction · doi:10.1530/rep.1.01076 · Cited by 408
TGF-β Signaling in Control of Cardiovascular Function
Goumans, M.-J., & ten Dijke, P. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022210 · Cited by 360
Consequences of knocking out BMP signaling in the mouse
Zhao, G. (2003) · genesis · doi:10.1002/gene.10167 · Cited by 358
The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis
Neel, J.-C., Humbert, L., & Lebrun, J.-J. (2012) · ISRN Molecular Biology · doi:10.5402/2012/381428 · Cited by 345
Mahlapuu, M., Ormestad, M., Enerbäck, S., & Carlsson, P. (2001) · Development · doi:10.1242/dev.128.2.155 · Cited by 332
Transforming growth factor-β: pleiotropic role in the regulation of hematopoiesis
Fortunel, N. O., Hatzfeld, A., & Hatzfeld, J. A. (2000) · Blood · doi:10.1182/blood.v96.6.2022 · Cited by 315
Harris, M. J., & Juriloff, D. M. (2007) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20333 · Cited by 314
Bone Morphogenetic Protein-2 Stimulates Angiogenesis in Developing Tumors
Langenfeld, E. M., & Langenfeld, J. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.141.2.3 · Cited by 284
Conditional inactivation of the TGF‐β type II receptor using Cre:Lox
Chytil, A., Magnuson, M. A., Wright, C. V. E., & Moses, H. L. (2002) · genesis · doi:10.1002/gene.10046 · Cited by 269
BMP signaling in vascular diseases
Cai, J., Pardali, E., Sánchez-Duffhues, G., & ten Dijke, P. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.030 · Cited by 269
Formation of the definitive endoderm in mouse is a Smad2-dependent process
Tremblay, K. D., Hoodless, P. A., Bikoff, E. K., & Robertson, E. J. (2000) · Development · doi:10.1242/dev.127.14.3079 · Cited by 178
Co-ordinating Notch, BMP, and TGF-β signaling during heart valve development
Garside, V. C., Chang, A. C., Karsan, A., & Hoodless, P. A. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1197-9 · Cited by 160
Defective pulmonary vascular remodeling in Smad8 mutant mice
Huang, Z., Wang, D., Ihida-Stansbury, K., Jones, P. L., & Martin, J. F. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp214 · Cited by 81
Pericytes, Microvasular Dysfunction, and Chronic Rejection
Kloc, M., Kubiak, J. Z., Li, X. C., & Ghobrial, R. M. (2015) · Transplantation · doi:10.1097/tp.0000000000000648 · Cited by 34
Metadata
- Authors
- Chang, H., Huylebroeck, D., Verschueren, K., Guo, Q., Matzuk, M. M., & Zwijsen, A.
- Venue
- Development
- Publisher
- The Company of Biologists
- Published
- 1999-04-15
- Volume
- 126
- Issue
- 8
- Pages
- 1631-1642
- ISSN
- 0950-1991 (ISSN-L)
- 1477-9129
- OpenAlex
- W2162238950
- Cited by
- 435
- References
- 61
- FWCI
- 10.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
